MACKENZIE FINANCIAL CORP
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 919859
TORONTO ONTARIO, A6
Position in RIGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$701,108
-$78,238 QoQ
Shares Held
17,922
-37.8% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 156 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $498,673,295 across 59 Biotechnology names. RIGL ranks #48 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,988 | $13,241,707 |
All Filings in RIGL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $701,108 | 17,922 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $779,346 | 28,822 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,013,443 | 23,662 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $829,842 | 29,292 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $708,499 | 37,827 | Shares | Sole | 2025-08-13 | |
| 2024-03-31 | $70,553 | 47,671 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $50,576 | 34,880 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $35,768 | 33,119 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $37,533 | 29,096 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $38,406 | 29,096 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $50,773 | 33,849 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $35,798 | 30,338 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $39,474 | 34,933 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $59,707 | 19,969 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $52,917 | 19,969 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $75,141 | 20,700 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $71,744 | 16,531 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $36,594 | 10,700 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $42,350 | 12,100 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $29,040 | 12,100 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $25,803 | 14,100 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||